Additionally, two categories of antidiabetic drugs, namely, dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium–glucose co-transporter-2 (SGLT2) inhibitors, are also used in the treatment of PCOS. This evidence concerns the gene SLC5A2 and polycystic ovary syndrome.